PRKAA1 and colorectal carcinoma: To evaluate the therapeutic effect on AMPKα1, we specifically developed a modified PPMS/shRNA polyplexes for efficient systemic gene delivery to manipulate the gene expression levels of AMPKα1 in CRC models.